Technical Articles

KRAS[G13D]/CRBN PROTAC Kit

Impact of KRAS Mutation Heterogeneity on Targeted Therapy and Novel Targeting Strategies for G13D

2026-01-23

Colorectal cancer is a common malignant tumor of the digestive tract, and overexpression of the epidermal growth factor receptor (EGFR) is one of its key driving factors.

View details

Cancer
KRAS[G13D]/CRBN PROTAC Kit
Colorectal cancer
Malignant tumor

Progress in the Development of KRAS[G13D]-Targeted Inhibitors and Degradation Strategies

2026-01-12

KRAS, the most frequently mutated member of the RAS family, plays a key driving role in human malignant tumors.

View details

Cancer
KRAS[G13D]/CRBN PROTAC Kit
Malignant tumor
Pancreatic cancer

Total 2

Go to